The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClontarf Regulatory News (CLON)

Share Price Information for Clontarf (CLON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0335
Bid: 0.032
Ask: 0.035
Change: -0.003 (-8.22%)
Spread: 0.003 (9.375%)
Open: 0.0365
High: 0.0365
Low: 0.0335
Prev. Close: 0.0365
CLON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Warrants and RPT

12 Jan 2022 16:40

RNS Number : 2637Y
Clontarf Energy PLC
12 January 2022
 

 

12th January, 2022

 

Clontarf Energy plc

("Clontarf" or "the Company")

 

Issue of Warrants to Directors

Related Party Transaction

 

 

Clontarf Energy plc (AIM:CLON), the energy company focused on Africa and Bolivia, has been accruing, and therefore not paying in cash, salaries of the current Directors since 2010. The aggregate accrued liability as at 31 December 2021 for the three longest serving directors (Dr Teeling, Mr Horgan and Mr Finn) is £1,340,564. The Board remains cognisant of the need to conserve cash resources in the current environment and therefore these three Directors have agreed to continue deferring payment of this amount, in cash, until the end of 2024.

 

In consideration for this past and continued deferral, these directors have been issued 3.25 warrants over Ordinary Shares per each 1p of accrued salary due until 31 December 2021 ("Warrants"). The Warrants are exercisable at 0.25p, being a 6% premium to the closing mid-market price yesterday, at any time until 11 January 2025 and have been allocated as follows:

 

Director

Accrued salary (£)

Warrants exercisable at conversion price of 0.25p per share

David Horgan

£569,037

184,937,025

John Teeling

£395,704.

128,603,800

James Finn

£375,823

122,142,475

 

Accordingly, in aggregate, 435,683,300 Warrants have been issued to the above Directors. Any exercise of the Warrants is restricted to the extent that, if by exercising, the Warrant holders in aggregate hold greater than 29.9% of the total voting rights of the Company.

 

For the avoidance of doubt, the deferred salaries, unless otherwise settled, will remain payable in cash after the end of 2024.

 

Related party transaction

 

The issue of the warrants to the three directors as set out above constitutes a related party transaction under Rule 13 of AIM Rules. In this context, Peter O'Toole, being the Director on the Board who is considered to be independent of the awards, considers, having consulted with the Company's nominated adviser, Strand Hanson Limited, that the terms of the issue of the warrants to the three directors are fair and reasonable insofar as its shareholders are concerned.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

Ends

 

 

For further information please visit http://clontarfenergy.com or contact:

 

Clontarf Energy

David Horgan, Executive Chairman

John Teeling, Non-Executive Director

+353 (0) 1 833 2833

Nominated & Financial Adviser

Strand Hanson Limited

Rory Murphy

Ritchie Balmer

Abigail Wennington

+44 (0) 20 7409 3494

Broker

Novum Securities Limited

Colin Rowbury

+44 (0) 207 399 9400

Blytheweigh - PRMegan RayAlice McLaren

Madeleine Gordon-Foxwell

 

+44 (0) 207 138 3206

+44 (0) 207 138 3553

+44 (0) 207 138 3206

+44 (0) 207 138 3206

 

Teneo

Luke Hogg

Alan Tyrrell

Ciara Wylie

+353 (0) 1 661 4055

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVRLEIFLIF
Date   Source Headline
25th Sep 20074:24 pmRNSAdditional Listing
14th Sep 20077:00 amRNSInterim Results
23rd Aug 20071:02 pmRNSAGM Statement
16th Aug 200712:07 pmRNSAIM Rule 26
27th Jun 20077:00 amRNSFinal Results
25th Jun 20077:01 amRNSDrilling Report
16th Jan 20077:00 amRNSDrilling Report
20th Dec 20064:02 pmRNSTotal Voting Rights
29th Nov 20067:00 amRNSDrilling Report
1st Nov 20063:17 pmRNSAdditional Listing
21st Sep 20067:00 amRNSInterim Results
5th Sep 200610:00 amRNSDrilling Report
1st Aug 20067:02 amRNSChange of Adviser
27th Jul 20061:00 pmRNSAGM Statement
25th Jul 20067:00 amRNSResearch Update
15th Jun 20067:30 amRNSFinal Results
26th May 20067:01 amRNSRe Agreement
12th Apr 20067:00 amRNSDirectorate Change
6th Dec 20057:30 amRNSDrilling Report
10th Oct 20057:00 amRNSResults from sampling
20th Sep 20057:00 amRNSInterim Results
14th Sep 20057:00 amRNSDrilling Report
7th Jul 20057:30 amRNSExploration Report
30th Jun 20058:00 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.